Gujarat

National Institute of Malaria Research (NIMR) was established in 1977 as 'Malaria Research Centre', which was renamed as 'National Institute of Malaria Research' in November 2005. NIMR is one of the institutes of the Indian Council of Medical Research (an autonomous body under Department of Health Research, Ministry of Health & Family Welfare, Govt. of India).

We are Rs. 6000 Crore diversified multi-product group engaged in manufacturing and marketing of Detergents, Soaps, vacuum Salt, Heavy Chemicals. Caustic Soda, Soda ash, Petrochemicals, Pharmaceuticals Formulation, Medical Disposable Devices Packaging & Printing Materials, and Fertilizers etc.

For our Pharmaceutical Division we invite individuals for following positions.

Shine Pharmaceuticals Ltd is a WHO-GMP and ISO Certified Pharmaceutical Formulations company having significant presence throughout India and International markets. Shine is engaged in the field of manufacturing and marketing of oral and injectable formulations in Neuropsychiatry, Cardiology. Anti-diabetics and Gastro segments. For expanding our business into new territories and strengthen our team, we require professionals for following positions.

Applications are invited for the JRF position supported by DBT sponsored project on Medical Mycology in Immunology group with Dr. Reena Rajput.

Walk-in Interview on 22nd October, 2012 at 11:00 am

About Authors:
K.S.Khatri
S.K.Patel education and research, Kherva,
Mehasana-384001
kkhatri_pharm@yahoo.com

Abstract:
Interest in transdermal drug delivery systems has increased on several fronts over the past several years because of the inherent advantages over the oral delivery such as the avoidance of gastrointestinal absorption, enzymatic and pH associated deactivation. Stratum corneum forms highly lipophilic membrane and provides the greatest resistance to penetration of drugs. A number of chemical and physical permeation enhancement techniques have been investigated. Chemical enhancers represent the most widely studied approach to transdermal drug permeation enhancement but are associated with toxicity, therefore limiting their clinical application. In recent years the emergence of number of physical techniques has expanded the range of drugs that can be delivered transdermally. Promising new technologies involved in enhancing transdermal permeation are Abrasion, Electroporation, Sonophoresis/Phonophoresis, Pressure waves, Iontophoresis, Laser Radiation,Magnetophoresis, Microneedles, Needleless injection and many more. In the present reviewed tried to discuss alternate techniques of enhancing the transdermal transport.

[adsense:336x280:8701650588]

About Author:
KIRANKUMAR K. VAGHASIYA
M.Sc. Biotechnology
Bhagwan Mahavir College Of  Biotechnology, Surat
* vaghasiyakiran51@yahoo.co.in

Abstract:
Biosensors can be excellent analytical tools for monitoring programs working to implement legislation.Biosensor are analytical devices which are capable of providing either qualitative or quantitative results. Biosensor technology to be in a very early stage of development. There are many market opportunities. In this article, biosensors for environmental analysis and monitoring are extensively reviewed. Examples of biosensors for the most important families of environmental   pollutants, including some commercial devices, are presented. Finally, future trends in biosensor development are discussed. In this context, bioelectronics, nanotechnology, environmental pollution, and especially biotechnology seem to be growing areas that will have marked influence on the development of new biosensing strategies in the next future.At present There are various types of biosensor available for the number of industrial and diagnostic Applications.

About Authors:
Nishant kumar singh
Research Fellow,
ICRI (Ahm) and Cranfield University
* nishantsingh.shree@gmail.com

ABSTRACT:
Over 3 decades HIV/AIDS have been a major globally accepted challenge, from endemic to a catastrophic pandemic & explodes globally. Estimates says 33.3 million HIV ^+ve and 2.6 million newly HIV infected people are in 2009. Since the beginning of epidemic, nearly 30 million people have died from AIDS related cause^[1].  From chimpanzees to human^[2] and then human to human (migration^[3], MSM, HS, IDU, MTC etc) and ultimately it transformed into pandemic. After 30 years we have advanced our treatment & Medicare knowledge of HIV and AIDS. Our scientist has developed several successful targets and drugs based on them, a highly effective therapy HAART currently in use (managing viral load & cell count for better patient survival rate) showing good results. Still HIV/AIDS is incurable, WHY? It shows the need of critical thinking from the very 1^st initial step i.e. TARGET. HIV itself is the target; biotech and Pharmaceutical Company must consider nanotechnology & homologous approach for CCR5. Though it seems that we have control over it but if this goes out same way, than one day just due to the HIV typical characteristic of mutation and recombination the worst Catastrophic sub Saharan-Africa epidemic will become Pandemic.[i]

About Authors:
Kiran K.Vaghasiya*, Alpesh J.Shiroya
Bhagwan Mahavir College Of  Biotechnology ,
Surat
*vaghasiyakiran51@yahoo.co.in

Abstract
Green biotechnologydeals with the use of environmentally-friendly solutions as an alternative to traditional agriculture, horticulture, and animal breeding processes. An example is the designing of transgenic plants that are modified for improved flavor, for increased resistance to pests and diseases, or for enhanced growth in adverse weather conditions. Genetically enhanced crops are one tool that could contribute to a more harmonious balance between food production and our surrounding environment.  The overall message is that biotech plants can, and already do, contribute positively to reducing CO2 emissions and anticipating the impact of climate change on food scarcity. This will increase as they are more widely adopted. This document aims to provide background information about the role green biotech currently plays, and can play in future, in helping to combat climate change.

National Innovation Foundation - India (NIF), Ahmedabad, a grant-in-aid institute under Department of Science and Technology, Government of India invites applications for following positions in NIF from highly